Anti-Fya antibodies as the cause of an unfortunate post-transplant course in renal transplant recipient

Annals of Transplantation

Volumn 13, Issue 1, 2008, Pages 48-52

  Watorek, Ewa ^a   Boratyńska, Maria ^a   Hałoń, Agnieszka ^a   Klinger, Marian ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

DARC; Duffy antigen; Kidney transplantation

Indexed keywords

ANTIBODY; ANTIGEN; BASILIXIMAB; COMPLEMENT COMPONENT C4D; CREATININE; DUFFY ANTIGEN; ERYTHROPOIETIN; FY A ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SODIUM MOFETIL; STEROID; TACROLIMUS; UNCLASSIFIED DRUG; ALLOANTIBODY; ANTI FY(A) ANTIBODY; ANTI-FY(A) ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ANEMIA; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARTERIOSCLEROSIS; ARTICLE; BLOOD GROUP B; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP RH; BLOOD GROUP TYPING; BLOOD TRANSFUSION; CADAVER DONOR; CASE REPORT; CELLULAR IMMUNITY; COLD ISCHEMIA; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; DIARRHEA; DRUG INTERMITTENT THERAPY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDEMA; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL SYMPTOM; GLOMERULOPATHY; GRAFT RECIPIENT; HEMODIALYSIS; HERPES ZOSTER; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; KLEBSIELLA OXYTOCA; LEUKOPENIA; LYMPHOCYTIC INFILTRATION; PERITONEAL DIALYSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PROLIFERATIVE GLOMERULONEPHRITIS; RECURRENT INFECTION; RENAL GRAFT DYSFUNCTION; REPERFUSION INJURY; SEROLOGY; UPPER RESPIRATORY TRACT INFECTION; UPREGULATION; URINARY TRACT INFECTION; URINE RETENTION; VASCULITIS; BLOOD; IMMUNOLOGY; LYMPHOCYTE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; NEUTROPHIL; PATHOLOGY; TREATMENT OUTCOME;

CREATININE; FEMALE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; LYMPHOCYTES; NEUTROPHILS; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 48549083091     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Mathew S, Chaudhuri A, Murty VV, Pogo AO: Confi rmation of Duffy blood group antigen locus (FY) at 1q22-23 by fl uorescence in situ hybridization. Cytogenet Cell Genet, 1994; 67: 68-71
2. Hoppe PA, Judd WJ, Ness P: Other blood group systems. In: Walker R (ed.) Technical Manual 10th Edition, American Association of Blood Banks 1117 North 19th Street Suite 600 Arlington, Virginia, 22209, 1990: 283
3. Hadley TJ, Peiper SC: From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood, 1997; 89: 3077-3091
4. Chaudhuri A, Polyakova J, Zbrzezna V, Pogo AO: The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malarial parasites specifi city and expression in nonerythroid tissues in Duffy-negative individuals. Blood, 1995; 85: 615-621
5. Tournamille C, Colin Y, Cartron JP, Le Van Kim C: Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nature Genet, 1995; 10: 224-228
6. Rios M, Chaudhuri A, Mallinson G et al: New genotypes in Fy(a-b-) individuals: nonsense mutations (Trp to stop) in the coding sequence of either FYA or FYB. British Haematol, 2000; 108: 448-454
7. Tamasauskas D, Powell V, Saksela K, Yazdanbakhsh K: A homologous naturally occurring mutation in Duffy and CCR5 leading to reduced receptor expression. Blood, 2001; 97: 3651-3654
8. Horuk R, Chitnis CE, Darbonne WC et al: A receptor of the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science, 1993; 261: 1182-1184
9. Hadley TJ, Lu Z, Waśniowska K et al: Postcapillary venule endothelial cells in kidney express a multispecifi c chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. J Clin Invest, 1994; 94: 1-7
10. Chaudhuri A, Nielsen S, Elkiaer ML et al: Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. Blood, 1997; 89: 701-712
11. Liu X-H, Hadley TJ, Xu L et al: Up-regulation of Duffy antigen receptor expression in children with renal disease. Kidney Int, 1999; 55: 1491-1500
12. Segerer S, Regele H, Mack M et al: The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis. Kidney Int, 2000; 58: 1546-1556
13. Segerer S, Bohmig GA, Exner M et al: When renal allografts turn darc. Transplantation, 2003; 7: 1030-1034
14. Dawson TC, Lentsch AB, Wang Z et al: Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). Blood, 2000; 96: 1681-1684
15. Mange KC, Park EL, Kamoun M et al: Duffy antigen receptor and genetic susceptibility of African Americans to acute rejection and delayed function. Kidney Int, 2004; 66: 1187-1192
16. Akalin E, Neylan JF: The infl uence of Duffy blood group on renal allograft outcome in African Americans. Transplantation, 2003; 75: 1496-1500
17. Lerut E, VanDamme B, Noizat-Pirenne F et al: Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection? Transfusion, 2007; 47: 28-40